VACCINES is a huge market with an annual growth rate of 16.52% from US$11.42 Billion in 2006 to US$21.05 billion by 2010. The Asia market has become increasingly important as India and China are experiencing robust growth in their respective vaccine markets.

However, shortages in Asian disease vaccines ER&D support, lack of qualified manufacturing facilities, inconsistencies in vaccine product quality and viral safety are the major challenges in the Asian vaccine market.

IBC’s International Congress VACCINES ASIA features 35 presentations by over 40 international and Asian speakers, attracting over 150 attendees on topical issues in the vaccines arena.

Conference track 1 consists of the latest innovative R&D studies and the use of novel technologies to provide you with insights to develop the next blockbuster vaccine; analyse current unmet needs and pinpoint where opportunities lie, and establish profitable partnerships and alliances on the spot at the event, where over 13 hours of networking is scheduled for you to bring home new contacts and new business leads.

Conference track 2 is where you can meet International and Chinese regulators and government officials face-to-face, learn and discuss latest regulatory guidelines and standards. Pioneering industry experts will share with you their strategies to create an effective manufacturing pipeline that complies with international regulatory guidelines, characterisation and scale-up strategies to maximize capacity and streamline production of safe and good quality vaccines.